Study Of GW679769 In Major Depressive Disorder

Clinical trial NCT00102492 · COMPLETED

Trial details

NCT number: NCT00102492
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Depressive Disorder, Major Major Depressive Disorder (MDD)

Start date: 2004-10-01
Primary completion: 2006-09-01
Enrollment: 356

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.